Core Laboratories N.V.CLBNYSE
Loading
CLB Revenue Growth (YoY Quarterly)•+6.98%
Stock Alarm Pro
Growth Metrics
Latest: Q4 2025vs Q3 2025
Revenue GrowthGross Profit GrowthEBITDA GrowthOperating Income GrowthNet Income GrowthEPS GrowthEPS Diluted GrowthWeighted Average Shares GrowthWeighted Average Shares Diluted GrowthDividends per Share Growth
+6.98%
+6.9pp
+29.41%
+20.6pp
+1.51%
-2.9pp
+1.88%
-3.8pp
-4.34%
-25.6pp
-6.25%
-26.3pp
-6.25%
-26.3pp
-0.70%
-1.0pp
-2.66%
-1.1pp
+0.00%
+0.0pp
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.80% | -4.67% | -0.32% | +0.09% | +6.98% |
| Gross Profit Growth | -27.42% | -3.81% | -4.56% | +8.82% | +29.41% |
| EBITDA Growth | -4.98% | -34.78% | +14.50% | +4.44% | +1.51% |
| Operating Income Growth | -2.79% | -48.47% | -4.48% | +5.68% | +1.88% |
| Net Income Growth | +236.65% | -104.78% | +17.76% | +21.23% | -4.34% |
| EPS Growth | +246.32% | -104.80% | +15.79% | +20.00% | -6.25% |
| EPS Diluted Growth | +220.00% | -104.89% | +15.79% | +20.00% | -6.25% |
| Weighted Average Shares Growth | -0.06% | -0.18% | +1.28% | +0.33% | -0.70% |
| Weighted Average Shares Diluted Growth | +0.45% | -1.95% | -0.49% | -1.55% | -2.66% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +6.10% | +20.43% | -14.17% | -35.08% | -61.59% |
| Free Cash Flow Growth | -3.66% | +24.48% | -29.38% | -47.26% | -73.44% |
| Receivables Growth | +3.48% | +1.12% | -2.13% | -5.59% | -10.86% |
| Inventory Growth | -17.15% | -16.52% | -14.49% | -11.07% | -8.26% |
| Asset Growth | +0.68% | +0.61% | +0.72% | -1.52% | +1.11% |
| Book Value per Share Growth | +12.16% | +9.35% | +7.37% | +7.86% | +11.80% |
| Debt Growth | -16.36% | -15.21% | -11.30% | -14.32% | +14.54% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +9.50% | +15.76% | +2.00% | +28.34% | +17.08% |
1 / 4